The cell and gene therapy contract development and manufacturing organization (cdmo) market is expected to grow significantly, with projections ranging from around $53.11 billion to $215.18 billion by 2035. The market size and growth rate vary across different reports, with some focusing on specific regions or applications, such as hearing loss gene therapy. The overall outlook suggests substantial growth in the cell and gene therapy market, with some reports also highlighting trends and challenges in outsourcing and advanced therapies.